Matinas BioPharma Holdings, Inc. (MTNB) › Total AssetsMatinas BioPharma Holdings, Inc. (MTNB) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $11.33M2014: $3.36M2015: $8.41M2016: $9.82M2017: $14.42M2018: $19.94M2019: $40.24M2020: $70.97M2021: $61.33M2022: $44.82M2023: $25.10M2024: $12.64M2025: $7.21M$7.21M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$7.21M-43.0%2024$12.64M-49.6%2023$25.10M-44.0%2022$44.82M-26.9%2021$61.33M-13.6%2020$70.97M+76.4%2019$40.24M+101.8%2018$19.94M+38.3%2017$14.42M+46.9%2016$9.82M+16.8%2015$8.41M+150.1%2014$3.36M-70.3%2013$11.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share